Bristol-Myers Squibb | BMY - Cost Of Sales

Stock Price
58.81
Daily Change
-1.78 -2.94%
Monthly
-1.33%
Yearly
16.29%
Q2 Forecast
57.45

Bristol-Myers Squibb reported $3.86B in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
AbbVie USD 4.22B 329M Mar/2026
Abbott USD 5.3B 380M Mar/2026
ALKERMES USD 46.21M 5.38M Dec/2025
Amgen USD 1.6B 187M Mar/2026
AstraZeneca USD -204M 3.48B Mar/2026
Biogen USD 797.5M 302M Mar/2026
Bristol-Myers Squibb USD 3.86B 1.07B Mar/2026
Coherus Biosciences USD 4.04M 324K Dec/2025
Drreddys Laboratories INR 40.46B 3.64B Dec/2025
Eli Lilly USD 3.58B 205M Mar/2026
Gilead Sciences USD 1.62B 50M Dec/2025
GlaxoSmithKline GBP 1.88B 736M Mar/2026
J&J USD 8.07B 103M Mar/2026
Medtronic USD 3.61B 83M Dec/2025
Merck USD 2.94B 380M Mar/2026
Novartis USD 3.54B 3M Dec/2025
Novo Nordisk DKK 15.15B 2.3B Dec/2025
Perrigo USD 747.4M 81.2M Dec/2025
Pfizer USD 6.29B 2.12B Dec/2025
Phibro Animal Health USD 240.42M 2.58M Dec/2025
Prestige Brands USD 131.22M 3.52M Dec/2025
Regeneron Pharmaceuticals USD 669.4M 84.8M Mar/2026
Roche Holding CHF 8.48B 4.61B Dec/2025
Sanofi EUR 3.67B 621M Mar/2026
Sanofi EUR 3.76B 344M Dec/2025
United Therapeutics USD 474.7M 373.8M Dec/2025
Zoetis USD 743M 60M Dec/2025